Edarbyclor is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals. The primary component is Azilsartan Kamedoxomil; Chlorthalidone.
| Product ID | 60631-412_04d4ae5d-27d1-43e6-876b-0037e6f174c0 |
| NDC | 60631-412 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Edarbyclor |
| Generic Name | Azilsartan Kamedoxomil And Chlorthalidone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-02-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202331 |
| Labeler Name | Arbor Pharmaceuticals |
| Substance Name | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE |
| Active Ingredient Strength | 40 mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Type 1 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Decreased Blood Pressure [PE],Thiazide-like Diuretic [EPC],Increased Diuresis [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2013-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202331 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-02-01 |
| Marketing End Date | 2014-08-13 |
| Marketing Category | NDA |
| Application Number | NDA202331 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-02-01 |
| Marketing End Date | 2017-05-31 |
| Marketing Category | NDA |
| Application Number | NDA202331 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-02-01 |
| Ingredient | Strength |
|---|---|
| AZILSARTAN KAMEDOXOMIL | 40 mg/1 |
| SPL SET ID: | e60f795b-fce3-4361-aa03-f143451689d1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |